KALAVSRXST• 12 Months (Normalized)
KALA vs RXST (KALA BIO Inc. vs RxSight Inc.)
Showing Closing Date Range from Sep, 14, 2025 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
KALA Performance $0.57
+%
KALA BIO Inc.
Normalized Baseline0.00%
RXST Performance $6
-35.05%
RxSight Inc.
Normalized Baseline0.00%
Alpha Spread Margin KALA LEADS
+35.05%
KALA outperforming by 35.05%
KALARXST
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
KALA RXST
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | KALA Price | KALA Gain (%) | RXST Price | RXST Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $- | $6.00 | -35.05% | - | |
| Sep 11, 2026 | $0.57 | -99.94% | $6.02 | -34.78% | -65.16% |
| Sep 10, 2026 | $0.56 | -99.94% | $5.96 | -35.43% | -64.51% |
| Sep 09, 2026 | $0.56 | -99.94% | $6.33 | -31.42% | -68.52% |
| Sep 08, 2026 | $0.54 | -99.94% | $6.45 | -30.12% | -69.82% |
| Sep 04, 2026 | $0.51 | -99.95% | $6.38 | -30.93% | -69.02% |
| Sep 03, 2026 | $0.56 | -99.94% | $6.54 | -29.14% | -70.80% |
| Sep 02, 2026 | $0.52 | -99.95% | $7.03 | -23.84% | -76.11% |
| Sep 01, 2026 | $0.53 | -99.94% | $6.99 | -24.27% | -75.67% |
| Aug 31, 2026 | $0.67 | -99.93% | $7.33 | -20.59% | -79.34% |
| Aug 28, 2026 | $0.69 | -99.93% | $7.05 | -23.62% | -76.31% |
| Aug 27, 2026 | $0.81 | -99.92% | $6.61 | -28.39% | -71.53% |
| Aug 26, 2026 | $0.82 | -99.92% | $6.38 | -30.88% | -69.04% |
| Aug 25, 2026 | $0.82 | -99.91% | $6.40 | -30.66% | -69.25% |
| Aug 24, 2026 | $0.80 | -99.92% | $6.26 | -32.18% | -67.74% |
Page 1 of 17